This one-hour, journal article-based activity examines ongoing clinical trials for cocaine use disorder (CUD) and evaluates how well ongoing studies align with recent Food and Drug Administration (FDA) recommendations. Learners will explore trends in trial design, including the use of pharmacologic, behavioral, device-based, and digital interventions, while examining common strengths and gaps in current research. The activity also discusses how adherence to regulatory guidance may influence the development, evaluation, and future implementation of effective treatments for CUD.

This 2-hour, on-demand session from the 2024 ASAM State of the Art Course focuses on the prevention and treatment of stimulant use disorders and will discuss topics such as new clinical practice guidelines, novel pharmacotherapies, methamphetamine-induced psychotic disorders, and more.

This 16-hour live course includes 9 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.

This one-hour, on-demand, journal article-based activity presents a scoping review on the efficacy of GLP-1 agonists in the treatment of patients with substance use disorder. While there is interest in exploring the use of GLP-1 agonists in the treatment of SUD, evidence for safety and efficacy of GLP-1 agonists in humans is limited. The results of this scoping review are mixed, and the authors call for further research to determine the efficacy of GLP-1 agonists in treating SUD.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses pharmacotherapy options for the management of stimulant use disorders.

This 75-minute on-demand session from the ASAM 55th Annual Conference addresses the findings of the highest impact articles in addiction medicine from 2023.

This 88-hour on-demand conference includes 71 sessions highlighting best practices and the latest science, research, and innovations in addiction medicine from leading experts in the field.